i-Optics

About i-Optics

i-Optics develops and provides advanced diagnostic solutions for ophthalmology, focusing on retina and cornea imaging. The company, founded in 2006 and headquartered in the Netherlands, designed technologies to empower surgeons and eyecare professionals with better decision-making tools. One of its key products is the Cassini, a corneal shape analyzer that utilizes patented multi-colored LED technology to measure both anterior and posterior corneal astigmatism, which is critical for planning premium cataract surgeries. Another significant product is the EasyScan, a zero-dilation retinal imaging system based on Scanning Laser Ophthalmoscope (SLO) technology. The EasyScan is designed for the early diagnosis of retinal diseases such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma, offering a patient-friendly experience by imaging through pupils as small as 2mm without the need for dilation.

The company's business model focused on providing these high-tech diagnostic devices to ophthalmologists, optometrists, and opticians to enhance patient care and clinical outcomes. The Cassini provides surgeons with detailed corneal data for improved toric IOL implantation and other refractive procedures, while the EasyScan offers a quick, three-minute eye care test suitable for retail optician settings to differentiate their services. The company also offered EyePrevent, an integrated screening service for retinal diseases in at-risk patients. Over its history, i-Optics raised a total of $36.4 million in funding over four rounds, with its last round being a Series E in May 2015. The company was led by CEO Jeroen Cammeraat, who was also an angel investor.